## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence as presented in the abstract; no access to full manuscript, figures, tables, or supplementary materials
- **Shared manuscript claim summary** The authors report a genome-scale characterization of the HexR transcription factor regulatory network in *Pseudomonas putida* KT2440, integrating transcriptomics of wild-type versus *hexR* deletion strains across four carbon substrates, ChIP-exo binding site identification, and model-based flux simulations. They claim extensive HexR control of acetate metabolism, 29 binding locations, direct regulation of 75 genes, and a holistic regulatory landscape relevant to metabolic engineering.
- **Visible evidence base** Abstract text only; no quantitative data, statistical details, or methodological specifics are provided
- **Missing materials affecting confidence** Full manuscript, all figures and tables, ChIP-exo data processing details, transcriptomic datasets, strain construction information, simulation model parameters, and any validation experiments

## Reviewer
- **Overall assessment** The abstract presents a potentially valuable contribution to understanding HexR regulation in a biotechnologically important organism. The integration of multiple systems biology approaches is commendable and aligns with current trends in regulatory genomics. However, the abstract alone provides insufficient detail to evaluate the robustness of the claims. Key quantitative results are stated without supporting statistics or methodological context, and the novelty relative to prior HexR studies is not clearly delineated. The claim of a "holistic view" appears overstated given the limited evidence presented in the abstract.
- **Who would be interested in the results, and why** Researchers in bacterial regulatory genomics, *Pseudomonas* biology, and metabolic engineering would find these results relevant. The identification of in vivo HexR binding sites and its regulon could inform strain engineering strategies for bioproduction. Those studying carbon metabolism regulation in Gram-negative bacteria may also find comparative value.
- **Major strengths** The multi-omics integration approach is methodologically ambitious and appropriate for the research question. The use of multiple growth substrates to capture condition-dependent regulatory behavior is a thoughtful experimental design. The combination of ChIP-exo with transcriptomics and in silico flux analysis provides a framework for comprehensive regulatory characterization.
- **Major Concerns** 
  - R1-M1
  - R1-M2
  - R1-M3
- **Minor Comments** 
  - R1-m1
  - R1-m2
  - R1-m3
- **Technical failings that need to be addressed before the case is established** The abstract does not provide evidence that the ChIP-exo data quality meets community standards, that the transcriptomic changes are statistically robust, or that the in silico simulations are validated against experimental flux measurements. Without these details, the central claims cannot be fully assessed.
- **Assessment against Nature-style criteria** 
  - Originality: The work appears to extend prior HexR studies by providing in vivo binding data, but the abstract does not clearly articulate what is genuinely new beyond incremental advancement. Assessment: moderate originality, not fully established from the abstract.
  - Scientific importance: Understanding HexR regulation in a key biocatalyst has practical relevance, but the broader conceptual advance for regulatory biology is not clearly demonstrated. Assessment: moderate importance.
  - Interdisciplinary readership: The topic bridges microbiology, genomics, and metabolic engineering, which could attract a cross-disciplinary audience. Assessment: potentially broad, but the abstract is written in a specialized manner.
  - Technical soundness: Cannot be evaluated from the abstract alone. The absence of methodological details and quality metrics prevents assessment. Assessment: not assessable.
  - Readability for nonspecialists: The abstract is concise and generally clear, though terms like "ChIP-exo" and "glyoxylate shunt" assume domain knowledge. Assessment: acceptable for a specialist journal, less so for a general audience.
- **Recommendation posture** Currently not established from the provided evidence. The abstract suggests a potentially solid study, but the lack of quantitative detail and methodological transparency prevents a supportive recommendation. A revised abstract with specific numbers, statistical measures, and clearer novelty statements could change this posture.

### Major Concerns

- **Concern ID** R1-M1
- **Severity** Major
- **Blocking** Yes
- **Axis** Evidence sufficiency
- **Claim pointer** The authors claim "extensive regulatory role of HexR in acetate metabolism, simultaneously suppressing the glycolytic pathway while enhancing pyruvate metabolism, glyoxylate shunt, and gluconeogenesis."
- **Evidence pointer** Abstract text; location not provided
- **Concern** The abstract states this regulatory role as a finding but provides no quantitative support, such as fold-change values, statistical significance, or the number of differentially expressed genes in each pathway. The directionality of regulation is asserted without showing how it was derived from the transcriptomic comparison.
- **Why it matters** This is a central claim of the study. Without quantitative evidence, the reader cannot assess the magnitude or reliability of the observed regulatory effects, nor compare them with prior studies on HexR function.
- **Resolution test** Provide specific differential expression statistics for key genes in glycolysis, pyruvate metabolism, glyoxylate shunt, and gluconeogenesis, with adjusted p-values and effect sizes, ideally in a supplementary table or figure.

- **Concern ID** R1-M2
- **Severity** Major
- **Blocking** Yes
- **Axis** Technical validation
- **Claim pointer** The authors claim identification of "29 HexR binding locations in the KT2440 strain grown on acetate, directly regulating 75 genes."
- **Evidence pointer** Abstract text; location not provided
- **Concern** ChIP-exo data require rigorous quality control, including peak calling thresholds, reproducibility across replicates, and motif validation. The abstract provides none of these details. The link between binding locations and "directly regulating 75 genes" implies a regulatory assignment that requires integration with expression data, but the method for this assignment is not described.
- **Why it matters** The number of binding sites and the inferred regulon size are headline results. If the peak calling or gene assignment criteria are not robust, these numbers could be misleading, affecting all downstream interpretations.
- **Resolution test** Describe the ChIP-exo analysis pipeline, including peak calling software, significance thresholds, replicate handling, and the criteria for assigning a binding site to a regulated gene. Provide a motif analysis showing enrichment of a HexR consensus sequence at the identified peaks.

- **Concern ID** R1-M3
- **Severity** Major
- **Blocking** Yes
- **Axis** Model validation
- **Claim pointer** The authors state that "model-based in silico simulations provided contextual insight into metabolic flux states."
- **Evidence pointer** Abstract text; location not provided
- **Concern** The nature of the model, its constraints, and its validation against experimental data are not described. It is unclear whether the simulations are genome-scale metabolic models, kinetic models, or another framework, and whether the predicted flux states were compared with any experimental measurements.
- **Why it matters** The simulation component is presented as a complementary pillar of the study. Without validation details, the "contextual insight" could be speculative and not add meaningful support to the experimental findings.
- **Resolution test** Specify the model type, the simulation conditions, and any experimental flux data used for validation. Show a comparison between predicted and measured flux distributions, with quantitative agreement metrics.

### Minor Comments

- **Concern ID** R1-m1
- **Severity** Minor
- **Axis** Clarity
- **Affected element** Experimental design description
- **Evidence pointer** Abstract text; location not provided
- **Issue** The choice of four growth substrates is stated, but the rationale for selecting these specific conditions is not explained. Glycerol is described as "inducing both metabolic responses," which is vague.
- **Required correction** Clarify the expected metabolic states for each substrate and why this set was chosen to capture the HexR regulatory range.

- **Concern ID** R1-m2
- **Severity** Minor
- **Axis** Novelty positioning
- **Affected element** Introduction of prior work
- **Evidence pointer** Abstract text; location not provided
- **Issue** The abstract mentions "previous research has explored HexR binding through in vitro assays and comparative transcriptomics," but does not specify what gap the current study fills beyond providing in vivo data.
- **Required correction** Explicitly state what is conceptually new, such as the discovery of condition-specific binding or a previously unknown regulatory role, to distinguish this work from prior studies.

- **Concern ID** R1-m3
- **Severity** Minor
- **Axis** Terminology precision
- **Affected element** Use of "holistic view"
- **Evidence pointer** Abstract text; location not provided
- **Issue** The phrase "holistic view of the HexR regulatory landscape" is broad and not supported by the specific claims listed. It may overstate the comprehensiveness of the study.
- **Required correction** Replace with a more precise description, such as "integrated view of HexR binding and expression under defined conditions," to match the evidence presented.

## Risk / unsupported claims
- The claim of "extensive regulatory role" in acetate metabolism is unsupported without quantitative expression data.
- The specific numbers "29 binding locations" and "75 genes" are unverifiable without ChIP-exo quality metrics and gene assignment criteria.
- The "model-based in silico simulations" claim is unassessable without model description and validation.
- The statement that the study "lays the groundwork for future metabolic engineering efforts" is a reasonable inference but is not directly supported by any demonstrated engineering application in the abstract.
- The overall framing of a "holistic view" is not supported by the limited evidence presented in the abstract.